Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

17.18
Delayed Data
As of 4:00pm ET
 +0.23 / +1.36%
Today’s Change
9.92
Today|||52-Week Range
19.98
+1.96%
Year-to-Date

Today’s Trading

Previous close16.95
Today’s open17.06
Day’s range16.76 - 17.42
Volume1,269,349
Average volume (3 months)1,122,092
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-75.68%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book356.69

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.11-2.01%
BLUEbluebird bio Inc+1.37+2.06%
ARIAARIAD Pharmaceutical...-0.02-0.15%
EXASExact Sciences Corp+0.89+5.03%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Search for Jobs